Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
Jongyoon Shinn(Ewha Womans University), Yonghyun Lee(Ewha Womans University), Seon Ju Lee(Ewha Womans University), Jung Seo Kim(Kumoh National Institute of Technology), Byungchae Jung(Kumoh National Institute of Technology), Joohyeon Kim(Kumoh National Institute of Technology), HyeonTaek Nam(Kumoh National Institute of Technology), Yejin Kim(Kumoh National Institute of Technology), Hyo Jin Kim(Korea National Institute of Health), Hyungjun Kim(Kumoh National Institute of Technology), Su Jin Kim(Inha University Hospital), Juyeon Lee(Kumoh National Institute of Technology), Tae Ho Kim(Kyungpook National University), Jonghee Choi(Kumoh National Institute of Technology), Cherin Lee(Ewha Womans University), Ah Hyun Choi(Ewha Womans University), Seon Ah Lee(Ewha Womans University)
Cited by 20
Related Papers
Smart pH-responsive nanomedicines for disease therapy
|Journal of Pharmaceutical Investigation|2022|108
Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy
|ACS Nano|2024|86
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
|Nature Communications|2023|84
PURIFICATION AND CHARACTERIZATION OF A SECRETORY SERINE PROTEINASE OF<i>ACANTHAMOEBA HEALYI</i>ISOLATED FROM GAE
|Journal of Parasitology|2000|75
Recent progress in development and applications of second near‐infrared (NIR-II) nanoprobes
|Archives of Pharmacal Research|2021|38